You are here

Selection of donor animals for the production of immune diagnostic sera against escherichiosis

The "One Health" strategy envisions the control of all processes in the food production chain “from farm to fork.” The detection of biotoxigens, including enterotoxigenic Escherichia coli, can be carried out by various methods. However, none of them can be classified as rapid methods. The fluorescent antibody technique (FAT), which combines the objectivity of microscopic methods with the high specificity of immunological reactions, may be applied in such a role. Analysis of FAO reports shows that monitoring for the presence of enteropathogenic E. coli is a vital part of the "One Health" strategy. The development of rapid methods for the indication and identification of enterotoxigenic E. coli is a current topic of scientific investigation, and FAT is one of such method. The diagnostic effectiveness of FAT depends on the activity and specificity of Escherichia coli sera, which in turn depends on the donor animals, immunization schemes, and antigenicity of the vaccine preparations. Objective of the Study is to perform a comparative assessment of two immunization schemes in different animal species using a vaccine preparation from inactivated E. coli microbial cells. As the vaccine preparation, a 5-billion suspension of microbial cells from a 24-hour culture of an enterotoxigenic β-hemolytic strain of E. coli grown in tryptone-soy yeast broth was used. The cells were inactivated with formaldehyde (0.4 % of culture volume) and concentrated with Aerosil A-300 (3 mg/ml). Rabbits, sheep, bulls, and horses (6 animals of each species) were used as donor animals. They were selected based on similarity in age, body weight, housing, and feeding conditions. All animals were clinically healthy. Two immunization schemes were used. In the first scheme, the vaccine was administered subcutaneously three times, and in the second – four times, at 4-day intervals in twofold increasing doses. Blood samples for testing were collected on the 21st day after the last vaccine administration. Agglutinin levels were determined using the agglutination reaction (AR). A 2-billion suspension of inactivated E. coli cells was used as the antigen. The reaction was performed in a volume of 1 cm³. The titer was defined as the last dilution of serum that showed agglutination of at least 2 pluses. The highest agglutinin titers were found in rabbit sera – 1:7253±1389 (first immunization scheme) and 1:9387±853 (second scheme). Slightly lower antibody titers were found in sheep – 1:5547±1028 (first scheme) and 1:8533±1079 (second scheme), and horses – 1:5973±1428 and 1:6827±1079 respectively. The lowest titers were found in bull sera – 1:4267±540 (first scheme) and 1:4693±427 (second scheme). This indicates that different animal species react differently to the same antigen. It was established that the difference in agglutinin levels between the second and first immunization schemes was 35% in sheep, 22.8% in rabbits, 12.5% in horses, and 9.1% in cattle. Thus, the fourth administration of the vaccine enhances the humoral response in immunized animals. However, it also causes stress and sensitization in the animals. Therefore, three administrations of the vaccine are sufficient for producing active Escherichia coli sera. During immunization with Escherichia coli antigen, the highest agglutinin titers were re corded in the sera of rabbits (1:9387±853) and sheep (1:8533±1079), slightly lower in horses (1:6827±1079), and the lowest in bulls (1:4693±427). The immunization scheme involving three parenteral administrations of the vaccine at 4-day intervals in twofold increasing doses stimulates a high level of agglutinins without causing stress, and therefore can be used for obtaining highly active escherichiosis diagnostic sera.

Key words: enterotoxigenic Escherichia coli, immunization schemes, vaccine preparations, donor animals, agglutination reaction, bacterial antigens.

  1. Vidal, R.M., Montero, D.A., Del Canto, F., Salazar, J.C., Arellano, C., Alvarez, A., Padola, N.L., Moscuzza, H., Etcheverría, A., Fernández, D., Velez, V., García, M., Colello, R., Sanz, M., Oñate, A. (2023). Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows. International Journal of Molecular Sciences, Vol. 24, no. 3, 2771 p. DOI:10.3390/IJMS24032771.
  2. Holovko, A.M., Napnenko, O.O. (2024). Biolohichna bezpeka ta biozakhyst – osnova protydiyi novym biolohichnym zahrozam i vyklykam [Biosafety and biosecurity are the basis for countering new biological threats and challenges]. Veterynarna medytsyna [Veterinary medicine]. Issue 110, рр. 5–7. DOI:10.36016/VM-2024-110-1. (in Ukrainian).
  3. Behas, V.L., Horbachova, V.P. (2024). Aspekty pravovoho rehulyuvannya pryntsypu «Yedyne zdorovʺya» v Ukrayini: Zbirnyk materialiv Vseukrayinsʹkoyi naukovo-praktychnoyi internet-konferentsiyi «Yedyne zdorovʺya»: realiyi i perspektyvy» [Aspects of legal regulation of the principle of “One Health” in Ukraine: collection of materials of the AllUkrainian scientific and practical Internet conference “One Health”: realities and prospects”]. Zhytomyr: PNU, рр. 6–9. (in Ukrainian).
  4. Вashchenko, M.I., Mandyhra, M.S., Stehniy, B.T., Herilovych, A.P. (2016). Aktualʹni problemy biolohichnoyi bezpeky v konteksti realizatsiyi stratehiyi MEB, VOOZ, FAO «Yedyne zdorov’ya» [Current issues of biological safety in the context of the implementation of the OIE, WHO, FAO “One Health” strategy]. Veterynarna medytsyna [Veterinary medicine], Issue 102, рр. 5–8. (in Ukrainian).
  5. Galaburda, M., Yustyniuk, V., Galat, M., Jokelainen, P. (2022). Jean Monnet Module “Integration of the EU One Health Framework and Policies in Ukraine” at the Faculty of Veterinary Medicine, University of Life and Environmental Sciences of Ukraine: proceedings of the International Scientific Conference "One Health". pp. 164–165.
  6. Lopez-Velez, R., Lebens, M., Bundy, L., Barriga, J., Steffen, R. (2022). Bacterial travellers’ diarrhoea: A narrative review of literature published over the past 10 years. Travel Med. and Infect. Disease, Vol. 47, рр. 1–13. DOI:10.1016/j.tmaid.2022.102293.
  7. Jenkins, С. (2018). Enteroaggregative Escherichia coli. Curr Top Microbiol Immunol. Vol. 416, рр. 27–50. DOI:10.1007/82_2018_105.
  8. Ramis, G., Pérez-Esteruelas, L., Gómez-Cabrera, C., de Pascual-Monreal, C., Gonzalez-Guijarro, B., Párraga-Ros, E., Sánchez-Uribe, P., Claver-Mateos, M., Mendonça-Pascoal, L., Martínez-Alarcón, L. (2022). Oral and Parenteral Vaccination against Escherichia coli in Piglets Results in Different Responses. Animals. Vol. 12, no. 20, 2758 p. DOI:10.3390/ani12202758.
  9. Boyko, O., Tytyuk, O., Panivsʹka, O., Poruchynsʹkyy, B., Boyko, P. (2021). Mozhlyvosti imunofluorestsentnoho metodu v laboratorniy diahnostytsi infektsiynykh khvorob [Possibilities of the immunofluorescence method in laboratory diagnostics of infectious diseases]. Notatky suchasnoyi biolohiyi [Notes of modern biology]. no. 1, Part 1, рр. 93–102. DOI:10. 29038/NCbio.21/1. (in Ukrainian).
  10. Boyko, O.P., Kurtyak, B.M., Senʹ, O.M., Romanovych, M.S., Sobko, H.V., Pundyak, T.O., Boyko, P.K. (2022). RA i RNHA – yak imunolohichni metody kontrolyu antyhennosti vaktsyn proty salʹmonelʹozu ptytsi [RA and RNGA – as immunological methods for controlling the antigenicity of vaccines against poultry salmonellosis]. Naukovyy visnyk LNUVMB imeni S.Z. Gzhytsʹkoho [Scientific Bulletin of the S.Z. Gzhytskyi National University of Veterinary Medicine]. Veterynarni nauky [Veterinary Sciences], Vol. 24, no. 105, рр. 102–108. DOI:10.32718/NVLVET10515. (in Ukrainian).
  11. Laramore, C.R., Moritz, C.W. (1969). Fluorescent antibody technique in detection of Salmonella in animal feed and feed ingredients. Appl. Microbial. Vol. 17, no. 3, рр. 352–354. DOI:10.1128/ am.17.3.352-354.1969.
  12. Atamas, V.A. (1968). Production of immunofluorescent lactoglobulin and its use for diagnosing calf paratyphoid. Prevention and Treatment of Diseases in Agricultural Animals in Southern Ukraine: Proceedings of the Odessa Agricultural Institute. no. 2, pp. 27–32.
  13. Bulatova, T.I., Ivanova, L.G., Matveev, K.I. (1971). Application of highly specific antibotulinum sera for detection of Clostridium botulinum types F and B using the luminescent-serological method. Journal of Microbiology, Epidemiology and Immunobiolog, no. 9, pp. 101–106.
  14. Batty, J., Walker, P.D. (1963). Differentiation of Clostridium septicum and Clostridium chauvoei by the use of fluorescent labelled antibodies. J. Pathol. Bact., Vol. 85, no. 2, рр. 517–521.
  15. Knox, A., Zerna, G., Beddoe, T. (2023). Current and Future Advances in the Detection and Surveillance of Biosecurity-Relevant Equine Bacterial Diseases Using Loop-Mediated Isothermal Amplification (LAMP). Animals. Vol. 13, no. 16, 2663 p. DOI:10.3390/ani13162663.
  16. Ahmad, M., Ahmed, I., Akhtar, T., Amir, M., Parveen, S., Narayan, E., Iqbal, H.M., Rehman, S. (2024). Strategies and innovations for combatting diseases in animals (Review). World Academy of Sciences Journal, Vol. 6, no. 6. DOI:10.3892/wasj.2024.270.
  17. Arshadi, N., Mousavi, S.L., Amani, J., Avicenna, N.S. (2020). Immunogenic Potency of Formalin and Heat Inactivated E. coli O157:H7 in Mouse Model Administered by Different Routes. J Med Bio technol., Vol. 12, no. 3, рр. 194–200.
  18. Montero, D.A., Garcia-Betancourt, R., Vidal, R., Velasco, J., Palacios, P.A., Schneider, D., Vega, C., Gómez, L., Montecinos, H., Soto-Shara, R., Oñate, Á., Carreño, L.J. (2023). A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxinproduc ing Escherichia coli in mice. Front Immunol. Vol. 27, no. 14, рр. 1–17. DOІ:10.3389/ fimmu.2023.1186368.
  19. Jarso, H.A., Eskeziyaw, M.B., Mengistu, Y.D., Tessema, S.T. (2024). Designing of immunodiagnostic assay using polyclonal antibodies for detection of Enteropathogenic Escherichia coli strains. PLOS ONE, Vol. 19, no. 12. DOI:10.1371/journal.pone.0315848.
  20. Chandler, H.M. (1975). Rabbit immunoglobulin responses to the flagella, somatic and protective antigens of highly protective strain of Clostridium chauvoei. Infection and Immunity. Vol. 12, no. 1, рр. 143–147. DOI:10.1128/iai.12.1.143-147.1975.
  21. Sharma, V.K., Schaut, R.G., Loving, C.L. (2018). Vaccination with killed whole-cells of Escherichia coli O157:H7 hha mutant emulsified with an adjuvant induced vaccine strain-specific serum antibodies and reduced E. coli O157:H7 fecal shedding in cattle. Vet Microbiol., Vol. 219, рр. 190 199. DOI:10.1016/j.vetmic.2018.04.003.
  22. Ivchenko, V.M., Sharandak, V.V., Horbatyuk, O.I., Abramov, A.V. (2006). Imunolohichni metody doslidzhenʹ v laboratoriyakh veterynarnoyi medytsyny [Immunological research methods in veterinary medicine laboratories]. Bila Tserkva: BTSNAU, 99 p. (in Ukrainian).
  23. Storz, H. (1983). Geretetechnik-bedingte problem bei der Immunfluoreszen-mikroskopie. Ztschr. Ges. Inn. Med. Vol. 38, pp. 101–104.
  24. Boyko, P.K. (1982). Immunofluorescent identification of the causative agent of emphysematous carbuncle: author's abstract of the dissertation ... candidate of veterinary sciences 16.00.03. M.: MVA, 24 p.
  25. McNeilly, T.N., Mitchell, M.C., Corbishley A., Nath, M., Simmonds, H., Mcteer, S.P., Mahajan, A., Low, J.C., Smith, D.G., Huntley, J.F., Gally, D.L. (2015). Optimizing the protection of cattle against Escherichia coli O157:H7 colonization through immunization with different combinations of H7 flagellin, Tir, Intimin-531 or EspA. PLoS ONE, Vol. 10, no. 5. DOI:10.1371/journal.pone.0128391.
  26. Berman, J.W. (1980). Amplification of the biotin-avidin immunofluorescence technique. J. Immunol. Methods., Vol. 36, no. 3–4, pp. 335–339. DOI:10.1016/0022-1759(80)90138-6.
  27. Rodríguez, M., Joseph, S., Pfeffer, M., Raghavan, R., Wernery, U. (2020). Immune response of horses to inactivated African horse sickness vaccines. BMC Veterinary Research. Vol. 16, no. 1. DOI:10.1186/s12917-020-02540-y.
  28. Shah, B.A., Avais, M., Khan, J.A., Rab bani, M., Anjum, A.A., Ali, M.A., Awais, M., Zaman, S.H., Mahmood, S., Ashraf, M., Ahmad, S. (2023). Evaluation of immunogenicity and dose dependent immune response against common bovine originated mastitogens in rabbit model. June, Vol. 33, no. 3. DOI:10.36899/japs.2023.3.0645.
AttachmentSize
PDF icon poruchynskyi_1_2025.pdf590.12 KB